Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses

Figure 3

The cardioprotective effects of Wog involved in activating Nrf-2-mediated antioxidant responses. (a) Western blot analysis of Nf-2 following siRNA transfection in H9C2 cells, where GAPDH was used as the loading control (); (b, c) the mRNA expression of Ho-1 and Nqo-1 by RT-qPCR (); (d, e) representative images of DCF staining from H9C2 cells (magnification: ×200, scale bar: 20 μm); (f, g) representative images of rhodamine-labeled phalloidin staining from H9C2 cells (magnification: ×200, scale bar: 20 μm). , , and compared to Ctrl; , , and compared to AngII; , , and compared to .

(a)

(b)

(c)

(d)

(e)

(f)

(g)